Neoadjuvant therapy for HER2-positive acantholytic squamous cell breast carcinoma: a case report

HER2-positive acantholytic squamous cell carcinoma (ASCC) of the breast is exceptionally rare, and its clinicopathologic features are poorly understood. The impact of neoadjuvant therapy on HER2-positive breast ASCC is unclear. Here we report on a 58-year-old woman who was diagnosed with HER2-positi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cong, Jia, Jo, HyonSu, Zou, Na, Kong, LingXin, Ri, HyokJu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566270/
https://www.ncbi.nlm.nih.gov/pubmed/37534455
http://dx.doi.org/10.1177/03000605231187936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566270/
https://www.ncbi.nlm.nih.gov/pubmed/37534455
http://dx.doi.org/10.1177/03000605231187936

Ejemplares similares